% Reaction Ref. List Template (Just copy the LaTeX generated table into this document in place of the currenttable and compile it using pdflatex etc. then convert it into html, then open it back into excel and 
% this makes a linkable references excel spreadsheet


\documentclass[a4paper, 12pt,epsfig, onecolumn]{article}
\pagestyle {plain}
%-------- packages to import for use ------------------
\usepackage{psfig}
\usepackage{graphics}
\usepackage{rotating}
\usepackage{pslatex}
\usepackage{mathptm}
\usepackage{makeidx}
\usepackage{pslatex}
\usepackage{moreverb,hangcaption}
\usepackage{longtable}
\usepackage{multicol}
\usepackage{subfigure}
\usepackage{comment}
%\usepackage{nature}
%\usepackage{naturefem}
%\usepackage{citesupernumber}



\usepackage{sfmath} 


\usepackage{html}
\usepackage{url} 

\usepackage[normal]{caption2}
\renewcommand{\tablename}{Supplementary Table}
\renewcommand{\captionlabelfont}{\bf}
\renewcommand{\captionlabeldelim}{ \textbf{$\vert$}}
\renewcommand{\captionmargin}{1cm} 


%-------------for dvi->ps -----------------------------
\usepackage{hyperref}
%\usepackage[dvips]{color}


\usepackage[section]{placeins}
\usepackage{colortbl}

%----------------- General Formatting -----------------------
\setlength{\textwidth}{14.5cm}     %setlength change the "distances"
%\setlength{\textheight}{24.0cm}
\setlength{\oddsidemargin}{0.6cm}
%\setlength{\evensidemargin}{0.6cm}
%\setlength{\topmargin}{-1.15cm}
%\setlength{\parindent}{1.5cm}
\pagenumbering{arabic}

%\newcommand{\mydot}[1]{\ensuremath{\hspace{-1mm} \cdot \hspace{-1mm}}
\newcommand{\mydot}{\hspace{-0mm} $\cdot$  \hspace{-0mm}}

% ----------begin latex input----------------------------------
\begin{document}

{\sf


\noindent
\textbf{Supplementary Table 1.}  List of compounds in the logical T-cell model. Model name
corresponds to the name in Fig. 1 and the Supplementary Table 2. Common
abbreviations are those usually used in the literature, while name is the
whole name. Type classifies the molecules, if applies, as follows: K =Kinase,
T=Transcription Factor, P = Phosphatase, A =Adaptor Protein, R = Receptor, G=
GTP-ase. In the   case where two pools of a molecule were considered, a'reservoir'  was included which was required for both pools. This allows to perform a simultaneous knock-out of both pools. 

% Table generated by Excel2LaTeX from sheet 'Sheet1'
\begin{longtable}{|p{0.03\textwidth}|p{0.1\textwidth}|p{0.17\textwidth}|p{0.485\textwidth}|p{0.06\textwidth}|}

\hline
  {\bf Nr} & {\bf Model Name} & {\bf Common \phantom{  } {abbreviation}} & {\bf Name} &{\bf Type} \\ \endhead 
\hline
         1 &  abl       &        Abl & Abelson protein tyrosine kinase &         K  \\
\hline
         2 &   akap79   &     Akap79 & A kinase (PRKA) anchor protein 79 &         A  \\
\hline
         3 &  ap1       &       Ap1  & v-jun sarcoma virus 17 oncogene homology &         T  \\
\hline
         4 &  bad       &        Bad & BCL2-antagonist of cell death  &            \\
\hline
         5 &    Bcat    &  ß-catenin & Catenin (cadherin-associated protein) beta 1 &            \\
\hline
         6 &   bcl10    &      BCL10 & B-cell CLL/lymphoma 10  &            \\
\hline
         7 &  bclxl     &     BCL2L1 & BCL2-like 1 &            \\
\hline
         8 &  ca        &   CA, Ca2+ &    Calcium &            \\
\hline
         9 &    cabin1  & Cabin1, CAIN & Calcineurin-binding protein &            \\
\hline
        10 &  calcin    & Calcineurin & Calcineurin &          P \\
\hline
        11 &  calpr1    &       Csp1 & Calcipressin 1 &            \\
\hline
        12 &   cam      &       CaM  & Calmodulin &            \\
\hline
        13 &   camk2    & Camk2,CamKII & calcium/calmodulin-dependent protein kinase (CaM kinase) II  &         K  \\
\hline
        14 &  camk4     & CamK4, CamKIV & calcium/calmodulin-dependent protein kinase IV &         K  \\
\hline
        15 &  card11a   & CARD11 + CARMA1 + BCL10 & Complex of CARD11, CARMA1, and BCL10, which is their fully active form (see Fig. 1) &            \\
\hline
        16 &    card11  & CARMA1, CARD11 & caspase recruitment domain family, member 11    &            \\
\hline
        17 &   cblb     &      Cbl-b & Cas-Br-M (murine) ecotropic retroviral transforming sequence b &            \\
\hline
        18 &     ccblp1 &     c-Cbl  & Casitase B-lineage lymphoma proto-oncogene (ZAP70-dependent pool) &         A  \\
\hline
        19 &  ccblp2    &      c-Cbl & Casitase B-lineage lymphoma proto-oncogene (Fyn-dependent pool) &         A  \\
\hline
        20 &   ccblr    &     c-Cbl  & Casitase B-lineage lymphoma proto-oncogene (Reservoir, see legend) &         A  \\
\hline
        21 &    cd28    &       CD28 & CD28 antigen (Tp44)    &         R  \\
\hline
        22 &  cd45      & CD45, PTPRC & protein tyrosine phosphatase, receptor type, C  &         P  \\
\hline
        23 &       cd4  &   CD4, p55 & CD4 antigen (p55)  &         R  \\
\hline
        24 &   cdc42    & CDC42, BB1 & cell division cycle 42 (GTP binding protein, 25kDa)    &         G  \\
\hline
        25 &    cre     &        Cre & cAMP responsive element binding protein 1  &            \\
\hline
        26 &  creb      & CREB, CREB1 & cAMP responsive element &         T  \\
\hline
        27 &      csk   &        Csk & c-src tyrosine kinase    &         K  \\
\hline
        28 &       cyc1 &       Cyc1 & cytochrome c-1    &            \\
\hline
        29 &    dag     &        DAG & Diacylglycerol &            \\
\hline
        30 &  dgk       &        DGK & diacylglycerol kinase &         K  \\
\hline
        31 &        erk & ERK, MAPK1 & Extracellular signal-regulated kinases, mitogen-activated protein kinase 1    &         K  \\
\hline
        32 &    fkhr    & FOXO1, fkhr & forkhead box O1A  &         T  \\
\hline
        33 &    fos     &   Fos, FRA & FOS-like antigen &            \\
\hline
        34 &       fyn  &        Fyn & FYN oncogene related to SRC, FGR, YES  &         K  \\
\hline
        35 &      gab2  &       Gab2 & GRB2-associated binding protein 2    &         A  \\
\hline
        36 &  gadd45    &    GADD45A & growth arrest and DNA-damage-inducible, alpha &            \\
\hline
        37 &    gads    & GRAP-2, GADS, P38 & GRB2-related adaptor protein 2   &         A  \\
\hline
        38 &      gap   &        GAP & GTPase-activating protein &            \\
\hline
        39 &       grb2 &       Grb2 & growth factor receptor-bound protein 2  &            \\
\hline
        40 &        sos &       Sos1 & Son of sevenless homolog 1 &            \\
\hline
        41 &    gsk3    &       GSK3 & glycogen synthase kinase 3 &         K  \\
\hline
        42 &  hpk1      & HPK1, MAP4K1 & Hematopoietic progenitor kinase 1, mitogen-activated protein kinase kinase kinase kinase 1   &         K  \\
\hline
        43 &   ikb      &        I$\kappa$B & Inhibitor protein I$\kappa$B &            \\
\hline
        44 &      ikkab & I$\kappa$KA + I$\kappa$KB & inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase alpha and kinase beta &            \\
\hline
        45 &     ikkg   &       I$\kappa$KG & inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma    &            \\
\hline
        46 &    ip3     &       IP3K & inositol 1,4,5-trisphosphate   &          K \\
\hline
        47 &   itk      &        ITK & IL2-inducible T-cell kinase &         K  \\
\hline
        48 &    jnk     & JNK, SAPK, MAPK8 & mitogen-activated protein kinase 8  &          K \\
\hline
        49 &      jun   &  JUN, ap1  & v-jun sarcoma virus 17 oncogene homolog &         T  \\
\hline
        50 &     lat    &        LAT & linker for activation of T cells &         A  \\
\hline
        51 &    lckp1   &        Lck & lymphocyte-specific protein tyrosine kinase ( CD4-dependent pool)    &          K \\
\hline
        52 &    lckp2   &        Lck & lymphocyte-specific protein tyrosine kinase  (CD28/TCR-dependent pool) &          K \\
\hline
        53 &     lckr   &        Lck & lymphocyte-specific protein tyrosine kinase (Reservoir, see legend)    &          K \\
\hline
        54 &     malt1  &      MALT1 & mucosa associated lymphoid tissue lymphoma translocation gene 1    &            \\
\hline
        55 &    mek     & MEK, MAP2K, MAPKK & mitogen-activated protein kinase kinase &          K \\
\hline
        56 &    mekk1   & MEKK1, MAP3K1, MAPKKK1 & mitogen-activated protein kinase kinase kinase &          K \\
\hline
        57 &   mkk4     & MKK4, MAP2K4, MAPKK4 & mitogen-activated protein kinase kinase 4  &          K \\
\hline
        58 &     mlk3   & MLK3, MAP3K11 & mitogen-activated protein kinase kinase kinase 11   &          K \\
\hline
        59 &      nfat  & NFATC1, NFATC2, NFATC3 & nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1    &         T  \\
\hline
        60 &    nfkb    &       Nf$\kappa$B & nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, 2 &         T  \\
\hline
        61 &       p21c & P21Cip1, Cdkn1a, p21 & cyclin-dependent kinase inhibitor 1A (p21, Cip1) &            \\
\hline
        62 &    p27k    & CDKN1B, p27Kip1 & cyclin-dependent kinase inhibitor 1B (p27, Kip1)  &            \\
\hline
        63 &     p38    & P38, MAPK14 & mitogen-activated protein kinase 14 &          K \\
\hline
        64 &    p70s    & RPS6KB1, p70s6k & ribosomal protein S6 kinase, 70kDa, polypeptide 1  &          K \\
\hline
        65 &      pag   &       PAG1 & phosphoprotein associated with glycosphingolipid microdomains 1  &         A  \\
\hline
        66 &     pdk1   & PDPK1, PDK1 & 3-phosphoinositide dependent protein kinase-1    &          K \\
\hline
        67 &      pi3k  & PI3K, PIK3CA & phosphoinositide-3-kinase, catalytic, alpha polypeptide   &          K \\
\hline
        68 &     pip3   &       PIP3 & Phosphatidylinositol (3,4,5)-trisphosphate &            \\
\hline
        69 &      pkb   &  PKB, AKT1 & v-akt murine thymoma viral oncogene homolog 1 &          K \\
\hline
        70 &     pkcth  & Prkcq, PKC-$\gamma$ & protein kinase C, theta  &          K \\
\hline
        71 &    plcga   & Active form of PLC$\gamma$1, PLC-gamma-1 & phospholipase C, gamma 1  &            \\
\hline
        72 &    plcgb   & PLCG1, PLC-$\gamma$-1 bound to LAT (but not active, see plcga) & phospholipase C, gamma 1  &            \\
\hline
        73 &      pten  &       PTEN & phosphatase and tensin homolog (mutated in multiple advanced cancers 1)    &         P  \\
\hline
        74 &    rac1p1  & RAC1, p21-Rac1, MIG5 & ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)  (Vav-1 dependent pool) &         G  \\
\hline
        75 &    rac1p2  & RAC1, p21-Rac1, MIG5 & ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)  (Vav-3 dependent pool) &         G  \\
\hline
        76 &     rac1r  & RAC1, p21-Rac1, MIG5 & ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) (Reservoir, see footnote)  &         G  \\
\hline
        77 &     raf    &       RAF1 & v-raf-1 murine leukemia viral oncogene homolog 1  &          K \\
\hline
        78 &     ras    &        Ras &        Ras &         G  \\
\hline
        79 &  rasgrp    &    RasGRP1 & Ras guanyl releasing protein 1 &            \\
\hline
        80 &      rlk   & TXK, RLK, TKL & TXK tyrosine kinase    &          K \\
\hline
        81 &     rsk    & RPS6KA1, RSK & ribosomal protein S6 kinase, 90kDa, polypeptide 1 &          K \\
\hline
        82 &     Sh3bp2 & 3BP2, SH3BP2 & SH3-domain binding protein 2   &         A  \\
\hline
        83 &      ship1 & INPP5D, SHIP1 & inositol polyphosphate-5-phosphatase, 145kDa   &         P  \\
\hline
        84 &     shp1   & Shp1, PTPN6 & protein tyrosine phosphatase, non-receptor type 6    &         P  \\
\hline
        85 &    shp2    & SHP2, PTPN11 & protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1)  &         P  \\
\hline
        86 &      slp76 & LCP2, SLP76 & lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)    &         A  \\
\hline
        87 &      sre   &        Sre & Serum responsive element &            \\
\hline
        88 &       tcrb &       TCR  & T-cell Receptor (bound to ligand) &         R  \\
\hline
        89 &     tcrlig &   PMHC, Ab & Ligand of T cell receptor (peptide-MHC complex or antibody) &         R  \\
\hline
        90 &      tcrp  &        TCR & T-cell Receptor phosphorylated &         R  \\
\hline
        91 &       vav1 &       VAV1 & Vav 1 oncogene &            \\
\hline
        92 &       vav3 &       VAV3 & Vav 3 oncogene &            \\
\hline
        93 &          X &          - & Non-identified kinase involved in CD28-mediated signaling (see main text) &          K \\
\hline
        94 &     zap70  &      ZAP70 & zeta-chain (TCR) associated protein kinase 70kDa  &          K \\
\hline
\end{longtable}  

}
\renewcommand{\familydefault}{\rmdefault} 

\newpage
%\bibliographystyle{/home/saezr/Repository/latex/naturemagnourl}
%\bibliographystyle{plos}
%\bibliography{/home/saezr/projects/struct_an/doc/tcr_documentation/tcr_bibs/tcr_bib}



\end{document}  























